Anti-inflammatory efficacy of low-dose cyclosporin A in psoriatic arthritis. A prospective multicentre study

British Journal of Dermatology

Volumn 135, Issue 5, 1996, Pages 752-757

  Mahrle, G ^a   Schulze, H J ^a   Brautigam M ^b   Mischer, P ^c   Schopf, R ^d   Jung, E G ^e   Weidinger, G ^b   Farber L ^b   Altmeyer, P ^f   Aubock J ^f   Baumann, S ^f   Fierlbeck, G ^f   Happle, R ^f   Haustein, U F ^f   Knopf, B ^f   Luger, T A ^f   Meyer, J ^f   Rainer, F ^f   Ruzicka, T ^f   Schopf E J ^f   Wassilew, S W ^f   Zaun, H O ^f   more..

^a UNIVERSITY OF COLOGNE   (Germany)

^b Product Development   (Germany)

^c Hospital of Wels   (Austria)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; RETINOID;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GASTROINTESTINAL DISEASE; HEADACHE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS;

EID: 10344250935     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1996.tb03885.x     Document Type: Article

References (39)

1. Ellis CN, Gorsulowsky DC, Hamilton TA et al. Cyclosporine improves psoriasis in a double-blind study. JAMA 1986; 256: 3110-16.
2. van Joost TH, Bos JD, Heule F et al. Low-dose cyclosporine A in severe psoriasis. A double-blind study. Br J Dermatol 1988; 118: 183-90.
3. Reitamo S, Kragballe K, Zachariae H et al. A multicenter study of cyclosporin in the plaque form of psoriasis: an interim report. In: Sandimmun (Cyclosporin) in Psoriasis (Kragballe K, Lumholtz B, eds). Copenhagen: FADL, 1989; 71-9.
4. Ellis CN, Fradin MS, Messana JM et al. Cyclosporine for plaque-type psoriasis. Results of a multi-dose, double-blind trial. N Engl J Med 1991; 324: 277-84.
5. Christophers K, Mrowitz U, Henneicke HH et al. Cyclosporine in psoriasis. A multicenter dose-finding study in severe plaque psoriasis. J Am Acad Dermatol 1992; 26: 86-90.
6. Ippolito F, Gianotti B, Massone L et al. Short- and long-term considerations, concerning the management of plaque psoriasis with low-dose cyclosporin. Dermatology 1993; 187 (Suppl. 1): 19-29.
7. Finzi AF, Mozzanica N, Pigatto A et al. Cyclosporin versus etretinate: Italian multicenter comparative trial in severe plaque-form psoriasis. Dermatology 1993; 187 (Suppl. 1): 8-18.
8. Lewis HM, Powles AV, Thomas E et al. Cyclosporin A in the treatment of chronic plaque psoriasis: six years experience. J Dermatol Treatment 1993; 4: 3-7.
9. Mahrle G, Schulze H-J, Färber L et al. Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement. J Am Acad Dermatol 1995; 32: 78-88.
10. Müller W, Graf U. Die Behandlung der Psoriasis-Arthritis mit Cyclosporin A, einem neuen Immunsuppressivum. Schwiez Med Wschr 1981; 111: 408-13.
11. Harper JI, Zemelman, V, Keat ACS et al. Cyclosporine for psoriasis: beneficial effect in refractory skin and joint disease. Transplant Proc 1988; 20 (Suppl. 4): 63-7.
12. Guptak AK, Matteson EL, Ellis CN et al. Cyclosporine in the treatment of psoriatic arthritis. Arch Dermatol 1989; 125: 507-10.
13. Steinsson K, Jonsdottir I, Valdimarsson H. Cyclosporin A in psoriatic arthritis: an open study. Ann Rheum Dis 1990; 49: 603-6.
14. Kokelj F, Lavaroni G, Stineo G. Psoriatic arthritis treated with cyclosporin A. Allergy Immunol 1992; 24: 393-4.
15. Salvarani C, Macchioni P, Boiardi L et al. Low-dose cyclosporine A in psoriatic arthritis: relation between soluble interleukin 2 receptors and response to therapy. J Rheumatol 1992; 19: 74-9.
16. Wagner SA, Peter RU, Adam O et al. Therapeutic efficacy of oral low-dose cyclosporin A in severe psoriatic arthritis. Dermatology 1995; 186: 62-7.
17. Riccieri V, Scavalli AS, Bracci M et al. Short-term 'cyclosporin A' therapy for psoriatic arthritis. Acta Derm Venereol (Stockh) 1994; Suppl. 186: 94-5.
18. Doyle DV, Huskisson EC, Greenwood A et al. Psoriatic arthritis (PsA) - A placebo controlled study of treatment with cyclosporine A (CyA) and azathioprine (Aza) (abstr.). Br J Rheumatol 1989; 28 (Suppl. 1): 53.
19. van Rijthoven AWAM, Dikjmans BAC, Goei THS et al. Cyclosporin treatment for rheumatoid arthritis: a placebo-controlled double-blind multicentre study. Ann Rheum Dis 1986; 45: 726-31.
20. Dougados M, Awada H, Amor B. Cyclosporin in rheumatoid arthritis: a double-blind controlled study in 52 patients. Ann Rheum Dis 1988; 47: 127-33.
21. Tugwell P, Bambardier C, Gent M et al. Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis. Lancet 1990; 335: 1051-5.
22. Isomäki H, Kvien TK (eds). Cyclosporin A in rheumatoid arthritis: aspects for long-term treatment. Proceedings of a meeting. Scand J Rheumatol 1992; 21 (Suppl. 95): 3-8.
23. Panayi GS, Tugwell P (eds). An international consensus report: the use of cyclosporin A in rheumatoid arthritis. Br J Rheumatol 1993; 32 (Suppl. 1): 1-78.
24. Forre Ø. Norwegian arthritis study group. Radiologic evidence of disease modification in rheumatoid arthritis patients treated with cyclosporine. Arthritis Rheum 1994; 37: 1506-13.
25. Landewe RBM, Goei THS, van Rijthoven AWAM et al. Cyclosporine in common clinical practice: an estimation of the benefit/ risk ratio in patients with rheumatoid arthritis. J Rheumatol 1994; 21: 1631-6.
26. Landewe RBM, Goei THS, van Rijthoven AWAM et al. A randomized, double-blind. 24-week controlled study of low-dose cyclosporine versus chloroquine for early rheumatoid arthritis. Arthritis Rheum 1994; 37: 637-43.
27. Krüger K, Schattenkirchner M. Comparison of cyclosporin A and azathioprine in the treatment of rheumatoid arthritis - results of a double-blind multicentre study. Clin Rheumatol 1994; 13: 248-55.
28. van Rijthoven AWAM, Dijkmans BAC, Goei THS et al. Comparison of cyclosporine and D-penicillamine for rheumatoid arthritis: a randomized, double-blind, multicentre study. J Rheumatol 1991; 18: 815-20.
29. Cohen S, Rutstein J, Luggen M et al. Comparison of the safety and efficacy of cyclosporine A and methotrexate in refractory rheumatoid arthritis: a randomized, multi-centered, placebo-controlled trial (abstr.). Arthritis Rheum 1993; 105: S56.
30. Ritchie DM, Boyle JA, McInnes JM et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med, New Series XXXVII, 1968; 37: 393-406.
31. Bellamy N, Buchanan WW. Clinical evaluation in rheumatic diseases. In: Arthritis and Allied Conditions (McCarty DJ, Koopman WJ, eds) Vol. 1. Philadelphia: Lippincott, 1993; 151-78.
32. Paulus EH, Williams HJ, Ward JR et al. Azathioprine versus D-penicillamine in rheumatoid arthritis patients who have been treated unsuccessfully with gold. Arthritis Rheum 1984; 27: 721-7.
33. Lee P, Baxter A, Dick WC et al. An assessment of grip strength measurement in rheumatoid arthritis. Scand J Rheum 1974; 3: 17-23.
34. Unsworth A, Haslock J, Vasandakumar V et al. A laboratory and clinical study of pneumatic 'grip strength' devices. Br J Rheum 1990; 29: 440.
35. Thompson PW, Silman AJ, Kirwan JR et al. Articular indices of joint inflammation in rheumatoid arthritis. Arthritis Rheum 1987; 30: 618-23.
36. Mazzanti G, Coloni L, De Sabbata G, Poladini G. Methotrexate and cyclosporin combined therapy in severe psoriatic arthritis. A pilot study. Acta Derm Venereol (Stockh) 1994; 186 (Suppl.): 116-17.
37. Zachariae H, Zachariae E. Methotrexate treatment of psoriatic arthritis. Acta Derm Venereol (Stockh) 1987; 67: 270-3.
38. Willkens RF, Williams HJ, Ward JR et al. Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritis. Arthritis Rheum 1984; 27: 376-81.
39. Lewis HM, Powler AV, Thomas K et al. Cyclosporin A in the treatment of chronic plaque psoriasis: six years experience. J Derm Treat 1993; 4: 3-7.